Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H20BrNO |
| Molecular Weight | 334.251 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN(C)CCOC(C1=CC=CC=C1)C2=CC=C(Br)C=C2
InChI
InChIKey=NUNIWXHYABYXKF-UHFFFAOYSA-N
InChI=1S/C17H20BrNO/c1-19(2)12-13-20-17(14-6-4-3-5-7-14)15-8-10-16(18)11-9-15/h3-11,17H,12-13H2,1-2H3
| Molecular Formula | C17H20BrNO |
| Molecular Weight | 334.251 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Bromodiphenhydramine also known as bromazine, is an antihistamine and anticholinergic agent, which was used to under brand name ambordyl. Ambordyfor was indicated for the treatment of allergic symptoms, but that usage, was discontinued. It was shown, that bromodiphenhydramine competed with free histamine for binding at HA-receptor sites and lead to a reduction of the negative symptoms brought on by histamine HA-receptor binding.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/22876948 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | AMBODRYL Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/2807428
Curator's Comment: The antihistamine compound promethazine (Pz) showed significant antibacterial action when tested against 124 strains of aerobic and 13 strains of anaerobic bacteria belonging to both Gram positive and Gram negative genera. Six Pz-sensitive strains were found to be simultaneously sensitive to similar non-conventional antimicrobics, e.g., methdilazine, bromodiphenhydramine. A high degree of synergism was observed in vitro when Pz was used in combination with methdilazine and bromodiphenhydramine.
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:50:31 GMT 2025
by
admin
on
Wed Apr 02 08:50:31 GMT 2025
|
| Record UNII |
T032BI7727
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QR06AA01
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
||
|
NCI_THESAURUS |
C29578
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
||
|
WHO-ATC |
R06AA01
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB01237
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
SUB05908MIG
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
59177
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
7132
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL1201245
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
DTXSID6022688
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
404
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
C61654
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
T032BI7727
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
T032BI7727
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
19759
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | RxNorm | ||
|
336
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
2444
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
C011410
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
204-238-8
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
m2698
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000088673
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
BROMAZINE
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY | |||
|
118-23-0
Created by
admin on Wed Apr 02 08:50:31 GMT 2025 , Edited by admin on Wed Apr 02 08:50:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
TARGET -> INHIBITOR | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |